Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,776
+$222 QoQ
Shares Held
56
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,544
of 1,603 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jackson, Grant Investment Advisers, Inc. holds $16,628,871 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
30,346 | $7,636,267 | |
| 2 | JNJ |
Johnson & Johnson
|
13,554 | $3,442,309 | |
| 3 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,533 | $1,610,490 | |
| 5 | AMGN |
Amgen Inc
|
2,382 | $862,569 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,529 | $203,340 | |
| 7 | PFE |
Pfizer Inc
|
6,680 | $160,854 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,035 | $130,761 |
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,776 | 56 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,554 | 56 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,720 | 56 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $7,181 | 56 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,776 | 56 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $6,242 | 56 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,449 | 56 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $6,441 | 56 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $5,961 | 56 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $5,416 | 56 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,654 | 56 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,704 | 56 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $5,650 | 56 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,152 | 56 | Shares | Sole | 2023-05-02 | |
| No filing history on record for this holder in this stock. | ||||||